Dr. Marrouche is Professor of Medicine in the Section of Cardiology at the Heart & Vascular Institute, Tulane University, where he is responsible for leading all clinical, analytical, and administrative efforts across Tulane University and its collaborating sites. His experience developing innovative research and clinical practices for the advancement of patient care, diagnosis, and treatment of heart arrhythmias has fully prepared him to lead this effort.

After receiving my medical degree from the University of Heidelberg, Germany and after completing several internships at numerous locations including infectious disease, pulmonary medicine, vascular surgery, cardiac surgery, general cardiology and electrophysiology, he accepted a faculty position at the Department of Internal Medicine (Cardiovascular Medicine) in Utah. In 2006, he created the Comprehensive Arrhythmia Research and Management Center (CARMA) bringing together a cross-departmental team of physicians, scientists, researchers, MRI and imaging specialists dedicated to work collaboratively to innovatively improve successful prediction and outcomes in the treatment of cardiovascular disease. The CARMA Center developed the Utah Classification System for stratifying patients based on the percent of fibrosis quantified with delayed enhancement MRI (DE-MRI), relative to the left atrial wall volume with the aim of delivering individualized care to arrhythmia patients. In addition, he is also the director of Western Atrial Fibrillation Symposium.

Dr. Marrouche’s research findings have been published in more than 200 peer-reviewed articles and prominent medical journals, including the New England Journal of Medicine, Circulation and Journal of the American Medical Association (JAMA). One of his most important studies is the CASTLE-AF trial that changed the treatment guidelines for patients with atrial fibrillation (AF) and heart failure.